Cryptome CEO resigns

By Melissa Trudinger
Tuesday, 19 October, 2004

Cryptome Pharmaceuticals (ASX: CRP) has announced that CEO Jeffrey Travis has resigned for personal reasons.

US expatriate Travis, who was appointed in January shortly after the company floated on the ASX, is expected to return to the US. The company plans to appoint an interim CEO in the near future.

TGA approves therapy for paediatric growth hormone deficiency

The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...

Immune cell boost could enable lasting vaccine protection

A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...

Genes influence when babies start walking

Genetics accounts for about a quarter of the differences in when children take their first steps,...

Content from other channels on our network

Demand surges for household batteries

Aussie execs to report emissions regardless of politics

Conspiracy mentality drives misinformation about EVs

Underwater noise modelling program to protect marine life

Mitigating the decline of FCAS prices

Nearing the peak: NSW elective surgery waiting list figures

Investment in new Bankstown Hospital reaches record $2 billion

Community pharmacy invites 'pop ins' this Men's Health Week

APNA is searching for its next CEO

Monash IVF extends scope of review after second embryo incident

Software-defined automation: powering the next generation of process industries

UTS to open Australia's largest spacecraft manufacturing facility

Navigating SIF logic solver selection: Why the Moore Industries SLA stands out

Heat exchangers expand ginger beer production in Bundaberg

Rotork joins Rockwell Automation’s Technology Partner Program